OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the American College of Cardiology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
The Potential for Retained Microbubbles	1380
Contents	1021
Unbiased COVID-19 Pandemic With Biased Global Recovery	867
Audio Summary	694
New Findings on Ascending Aortic Dilation in Coarctation of the Aorta	531
Accuracy of Wearable Heart Rate Monitors During Exercise in Sinus Rhythm and Atrial Fibrillation	478
Risk Scores for Mortality Prediction After Transcatheter Mitral Valve Repair	444
Coarctation of Aorta With Tricuspid Aortic Valve Is Not Associated With Ascending Aortic Aneurysm	394
Contents	368
Contents	331
Evaluation of the Inclisiran Safety in High-Risk Populations	311
Detection of Vulnerable Plaque With Intravascular Imaging	283
Fishing CHIPs to Predict Postoperative Atrial Fibrillation	279
LEFT ATRIAL VOLUME INDEX ASSOCIATED WITH RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION: META-ANALYSIS AND SYSTEMATIC REVIEW	263
IMPACT OF HIV INFECTION ON THE OUTCOMES OF HOSPITALIZED PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: ANALYSIS OF NATIONAL INPATIENT SAMPLE	258
Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease	257
Prediction of Cardiac Arrest	235
Mind the Denominator	235
Audio Summary	228
Optical Coherence Tomography or Intravascular Ultrasound for Complex PCI	225
Reply	224
Transforming Publishing	224
Decreasing Unnecessary Invasive Coronary Angiograms With Photon-Counting Detector Coronary Computed Tomography Angiography	223
Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications	223
Percutaneous DLC-Based Total Cavopulmonary Assist Achieves 96-Hour Survival in Lethal Cavopulmonary Failure Sheep	220

Audio Summary	217
Audio Summary	195
Hypertrophic Cardiomyopathy in the General Population	194
Contents	189
Reply	184
Reply	174
RESPONSE: Do Pulmonary Embolism Response Teams Result in Improved Outcomes in Patients With Pulmonary Embolism?	174
Strengthening Global Partnerships to Combat Cardiovascular Disease	173
Audio Summary	169
2025 Acute Coronary Syndromes Guideline-at-a-Glance	167
Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI	163
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes	157
The High Stakes of High Decibels	155
Contents	155
Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis	154
The Dynamic Equilibrium of Heart Valve Transplantation	151
The Essential Role of Cardiovascular Surgery in Cardiology	148
Domino Heart Valve Transplant in Children With Congenital Valve Disease	148
Days Alive Out of Health Care	147
Ventricular Assist Device Utilization for Children With Congenital Heart Disease	144
A Bright Future for Tricuspid Repair Success	144
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring	139
Genetic Insights on the Relation of Vascular Risk Factors and Cervical Artery Dissection	136
Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease	134
A Genetic Dissection of Vascular Risk Factors for Cervical Artery Dissection	134
Lipoprotein(a)	133
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes	132
Genetic Testing for Cardiovascular Disease	131
Audio Summary	129
The Value of Case-Based Learning in Cardiovascular Medicine	129
Contents	125
CONGENITAL HEART DEFECTS AND THE SEVERITY OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER, A META-ANALYSIS.	123
FONTAN CIRCULATION IS MORE THAN JUST THE HEART	122
FACTORS AFFECTING SURVIVAL IN PATIENTS WITH FONTAN PHYSIOLOGY AN ELECTRONIC HEALTH RECORD DERIVED COHORT	120
PREDICTORS OF FAILURE OF PRIMARY BIVENTRICULAR REPAIR IN NEONATES WITH BORDERLINE LEFT VENTRICLE	119
A CASE OF ARTERIAL NON-ATHEROSCLEROTICTHROMBOTIC STROKE IN A PATIENT WITH ELEVATED LP(A)	119
USING QUALITY IMPROVEMENT TOOLS TO DECREASE LENGTH OF STAY AFTER FONTAN SURGERY IN PEDIATRIC PATIENTS WITH SINGLE VENTRICLE - TYPE CONGENITAL HEART DISEASE	119
TCT-440 Intermediate-Term Outcomes Following Transcatheter Aortic Valve Implantation in Patients With a History of Chest Radiation Therapy: A Propensity Score Matched Analysis	119
TCT-434 Abstract Withdrawn	119
POST-CABG MULTIVESSEL ISCHEMIA AND TRANSIENT ISCHEMIC DILATION ON NUCLEAR STRESS TESTING DUE TO SUBCLAVIAN STEAL SYNDROME	117
LOST IN THE ECHO: PULMONARY HYPERTENSION & CARDIAC PLASMACYTOMA	117
SUDDEN DETERIORATION OF CPAP ADHERENCE AFTER MYOCARDIAL INFARCTION - POTENTIAL EFFECT OF ACEI-INDUCED AIRWAY HYPER-RESPONSIVENESS	116
SEVERE GESTATIONAL HYPERTRIGLYCERIDEMIA IN A PATIENT WITH FAMILIAL HYPERCHYLOMICRONEMIA SYNDROME	115
UTILITY OF SURVEILLANCE ECHOCARDIOGRAMS FOLLOWING TRANSCATHETER PULMONARY VALVE REPLACEMENT IN ADULTS WITH CONGENITAL HEART DISEASE	114
INCIDENTAL DETECTION OF AN UNUSUALLY LOCATED CARDIAC PAPILLARY FIBROELASTOMA (CPF) OF THE RIGHT ATRIUM DURING WORK UP OF RIGHT BUNDLE BRANCH BLOCK (RBBB)	114
A TIGHT SQUEEZE: INTERARTERIAL COURSE OF AN ANOMALOUS RIGHT CORONARY ARTERY PRESENTING AS EPISODIC EXERTIONAL CHEST DISCOMFORT IN AN ATHLETE WITH A FIBRILLIN VARIANT OF UNKNOWN SIGNIFICANCE	114
CAN THE OCCLUDED PULMONARY ARTERY BE RECONSTITUTED?	112
FONTAN PATHOPHYSIOLOGY AND PLASMA BILE ACIDS	111
BEDSIDE BREATHLESSNESS AND BARORECEPTOR FUNCTION ASSESSMENT IN CONGESTIVE HEART FAILURE	111
TCT-452 Predictors of Prolonged Hospitalization After Transcatheter Aortic Valve Implantation	110

CARDIOGENIC SHOCK DUE TO PAXLOVID INTERACTION	110
DOUBLE TROUBLE: SEVERELY ELEVATED LDL DUE TO CONCOMITANT FAMILIAL HYPERLIPIDEMIA AND NEPHROTIC SYNDROME	108
TUMOR, THROMBUS, OR BOTH? THE ENIGMA OF A LEFT ATRIAL MASS IN A PATIENT WITH COVID-19	107
FLUOROURACIL INDUCED CORONARY VASOSPASM: A SUCCESSFUL INFUSION RECHALLENGE FOLLOWING PRETREATMENT PROPHYLAXIS	107
DOUBLE-HETEROZYGOUS APOB/PCSK9 VARIANTS AND UNIQUE ATTENUATED RESPONSES TO DIFFERENT THERAPIES	106
HYPOXIA IN A PATIENT WITH LARGE PATENT FORAMEN OVALE AND PULMONARY HYPERTENSION	106
INITIAL DIURETIC DOSING, MEASURES OF DIURESIS, AND OUTCOMES IN PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATED HEART FAILURE	106
SEVERE PULMONARY HYPERTENSION FOLLOWING CORONAVIRUS-19 INFECTION IN A PATIENT WITH PRIOR SPLENECTOMY	105
3 YEAR OUTCOMES OF TRANSCATHETER MITRAL VALVE-IN-VALVE, VALVE-IN-RING AND VALVEIN-MITRAL ANNULAR CALCIFICATION: RESULTS FROM THE MITRAL TRIAL	105
AORTIC VALVULITIS POST-CORONAVIRUS DISEASE 2019	104
INTENTIONAL TAXUS BACCATA INGESTION PRESENTING WITH CARDIOGENIC SHOCK AND VENTRICULAR TACHYCARDIA	103
AORTIC VALVE LEAFLET TEAR: A COMPLICATION OF IMPELLA DEVICE PLACEMENT	103
UNCLOGGING THE DRAIN -SUCCESSFUL REVASCULARIZATION STRATEGY IN STENTING OF ACQUIRED PULMONARY VEIN STENOSIS, MASQUERADING AS RECURRENT PLEURAL EFFUSION	102
PERCUTANEOUS DEBULKING OF AMITRAL VALVE VEGETATION: A NOVEL THERAPY FOR THE TREATMENT OF NONBACTERIAL THROMBOTIC ENDOCARDITIS	101
THE ASSOCIATION BETWEEN SIX-MINUTE WALK TEST PERFORMANCE AND MORTALITY IN PATIENTS WITH HIGH MULTIMORBIDITY BURDEN IN CARDIAC REHABILITATION	100
EXERCISE TRAINING INCREASES TOXIC PROTEIN OLIGOMERS UPTAKE FUNCTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS IN PATIENTS WITH HEART FAILURE	100
SELF-PERCEPTIONS OF HEALTH AND QUALITY OF LIFE AMONG ADULTS WITH CONGENITAL HEART DISEASE BY SEVERITY: A REPORT FROM CHD PULSE	99
SAVING THE KIDNEYS - SUCCESSFUL USE OF THE AORTIX DEVICE IN A PATIENT WITH LOW CARDIAC OUTPUT STATE AND SEVERE CARDIORENAL SYNDROME AWAITING HEART-KIDNEY TRANSPLANTATION: A CASE REPORT	99
SAFETY AND EFFECTIVENESS OF A LOW MOLECULAR WEIGHT HEPARIN IN PULMONARY EMBOLISM ASSOCIATED WITH CHEMOTHERAPY-INDUCED HEART FAILURE AND SEVERE THROMBOCYTOPENIA	99
THE EVOLUTION OF TRANSCATHETER EDGE TO EDGE REPAIR WITH MITRACLIP AND ITS OUTCOMES IN SECONDARY MITRAL REGURGITATION	99
MEDICAL THERAPY VS. REVASCULARIZATION IN LEFT MAIN CORONARY ARTERY DISEASE WITH PROVEN ISCHEMIA: INSIGHTS FROM THE DEFINE-LM REGISTRY	98
FROM SEPSIS TO STEMI: A CASE OF SHIFTING LEFT VENTRICULAR OBSTRUCTION	98
A RARE CASE OF PARADOXICAL MCCONNELL'S SIGN AND PSEUDO WELLEN'S PATTERN IN PATIENT WITH PULMONARY EMBOLISM	97
TCT-465 Abstract Withdrawn	96
SOCIAL AND EDUCATIONAL OUTCOMES AMONG ADULTS WITH CONGENITAL HEART DISEASE BY SEVERITY: A REPORT FROM THE CONGENITAL HEART DISEASE PROJECT TO UNDERSTAND LIFELONG SURVIVOR EXPERIENCE (CHD PULSE)	96
EFFECTS OF SALT SUBSTITUTES ON BLOOD PRESSURE AND CLINICAL OUTCOMES IN DIFFERENT POPULATION GROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS	95
CLINICIANS UNDERESTIMATE OBJECTIVE AND SUBJECTIVE SYMPTOM BURDEN IN CARDIAC SARCOID PATIENTS	95
AN AGGRESSIVE CASE OF NATIVE MITRAL VALVE ENDOCARDITIS	95
TRANSCATHETER PULMONARY VALVE REPLACEMENT FOLLOWING THE ROSS OPERATION IN ADULTS: A SINGLE CENTER EXPERIENCE	94
RED WINE REMODELS GUT MICROBIOTA INDEPENDENTLY OF TRIMETHYLAMINE N-OXIDE LEVELS	94
SAFETY AND EFFICACY OF BEMPEDOIC ACID IN PATIENTS WITH RENAL IMPAIRMENT	93
WHIPPLE-ING IN THE VALVES: TROPHERYMA WHIPPLEI BIOPROSTHETIC VALVE INFECTIVE ENDOCARDITIS REQUIRING REPLACEMENT AND AORTIC ROOT GRAFTING COMPLICATED BY HEART BLOCK	92
TCT-477 Household Income and Readmissions After TAVR	91
A CASE OF IGG4-RELATED AORTITIS PRESENTING AS ABDOMINAL PAIN	91
A COMBINED APPROACH USING HIGH-SENSITIVE TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE FOR RISK STRATIFICATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019	91
TCT-478 Long-Term 10 Years’ Follow-Up for Valve Dysfunction and Mean Gradient Change in Transcatheter Aortic Valve Replacement (TAVR)	90
MONKEYPOX MYOCARDITIS	89
ASSOCIATION BETWEEN CIRCULATING KETONE BODIES AND CARDIOVASCULAR OUTCOMES AMONG PARTICIPANTS OF THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)	88
CAUTION WITH CHLOROQUINE: A CASE OF CHLOROQUINE CARDIOTOXICITY	87
AN UNCOMMON CAUSE OF A CARDIAC MURMUR	87
ST ELEVATION IN A PATIENT WITH SARS-COV-2 PRESENTED WITH CHEST PAIN: ACUTE CORONARY SYNDROME OR BRUGADA PATTERN	86
TCT-483 Short-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid vs Tricuspid Aortic Valve Disease: Analysis From the Nationwide Readmissions Database (2017-2019)	86
PREDICTION OF FONTAN OUTCOMES USING T2-WEIGHTED MRI RADIOMIC FEATURES AND MACHINE LEARNING	86
THE HARMS ASSOCIATED WITH INFERIOR VENA CAVA FILTERS	85
ACUTE HEART FAILURE DUE TO MOLAR PREGNANCY-INDUCED THYROID STORM	84
GENDER DISPARITIES IN REJECTION OF STATIN THERAPY AND DELAYS IN ACHIEVEMENT OF LDL CONTROL AMONG PATIENTS AT HIGH CARDIOVASCULAR RISK	84
PUTTING A SOCK IN IT- IMPACT OF OWLET SMARTSOCK ON RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN INFANTS WITH SUPRAVENTRICULAR TACHYCARDIA	84
RISK FACTORS FOR EARLY PULMONARY HOMOGRAFT DYSFUNCTION IN CONGENITAL HEART DISEASE	82
EFFICACY AND SAFETY OF EARLY LIPID LOWERING TREATMENT IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA	82
LIPOPROTEIN(A) AND CARDIOVASCULAR OUTCOMES IN WOMEN AND MEN AFTER AN ACUTE CORONARY SYNDROME: A POST HOC ODYSSEY OUTCOMES TRIAL ANALYSIS	82
TRANSIENT SEVERE MITRAL VALVE REGURGITATION: AN EXTREMELY RARE CAUSE OF RECURRENT PULMONARY EDEMA	82
THE ROLE OF TARGETED TEMPERATURE MANAGEMENT POST-VENTRICULAR FIBRILLATION IN THE COVID19 POSITIVE PATIENT	81
POST PARTUM MANIFESTATION OF ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA (ARVD)	81
EVALUATION OF THE OPEN-CLEAN CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION PERFORATION SCORE IN THE PROGRESS-CTO REGISTRY	81
THE CURRENT CULTURE OF INTERVENTIONAL CARDIOLOGY: PROGRESSIVELY CHANGING OR STATUS QUO?	79
COVID-19 FULMINANT MYOCARDITIS PROGRESSING TO CARDIAC TAMPONADE IN LESS THAN 24 HOURS	79
BIPOLAR RADIOFREQUENCY SEPTAL ABLATION FOR RESISTANT LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION FOLLOWING TRANSCATHETER MITRAL VALVE REPLACEMENT IN MITRAL ANNULAR CALCIFICATION	79
PREDICTING MAINTENANCE OF AN IMPROVED EJECTION FRACTION	78
TCT-501 Cost-Effectiveness of Transcatheter Aortic Valve Replacement: SAPIEN 3 vs CoreValve Evolut R	78
EFFICACY AND SAFETY OF DUAL ANTIPLATELET THERAPY VERSUS DIRECT ORAL ANTICOAGULANT FOLLOWING LEFT ATRIAL APPENDAGE CLOSURE - A SYSTEMATIC REVIEW AND META-ANALYSIS	77
NOT JUST DKA: ISOLATED ANTEROLATERAL PAPILLARY MUSCLE INFECTIVE ENDOCARDITIS	77
A RARE CASE OF PERSISTENT THEBESIAN VEIN SYNDROME MASQUERADING CONSTRICTIVE PERICARDITIS	77
FROM 13% TO 60%: A RARE CASE OF MULTISYSTEM INFLAMMATORY SYNDROME IN ADULTS 4 WEEKS FOLLOWING COVID-19 INFECTION	77
IN-HOSPITAL OUTCOMES OF PERCUTANEOUS TRICUSPID VALVE REPAIR AND REPLACEMENT	76
TOP 100 SOCIAL MEDIA INFLUENCERS IN THE FIELD OF CARDIOLOGY	76
SINUS VENOSUS ATRIAL SEPTAL DEFECT WITH RIGHT ANOMALOUS PULMONARY VENOUS CONNECTIONS LEADING TO HEART FAILURE	76
GEOGRAPHIC DISTRIBUTION AND CLINICAL OUTCOMES AMONG PATIENTS WITH TRANSCATHETER MITRAL VALVE REPAIR IN THE UNITED STATES	76
TEN YEAR TRENDS AND AGE DIFFERENCES IN PERCUTANEOUS ATRIAL SEPTAL DEFECT CLOSURE	75
FULMINANT MYOCARDITIS SECONDARY TO COCAINE ABUSE REQUIRING VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION	75
EICOSAPENTAENOIC ACID (EPA) INCREASES HEME OXYGENASE-1 EXPRESSION IN MACROPHAGES AND ENDOTHELIAL CELLS DURING INFLAMMATION	75
TH1 IMMUNOLOGIC RESPONSE IN CORONARY MICROVASCULAR DYSFUNCTION	75
DECIEVED BY DESMOPLAKIN: AN INFLAMMATORY PRESENTATION OF ARRHYTHMOGENIC CARDIOMYOPATHY	75
CARDIOVASCULAR RISK REDUCTION IN PATIENTS WITH HYPERTENSION USING A DIGITAL THERAPEUTICS PLATFORM	74
SUCCESS OF LEAD EXTRACTION USING MANUFACTURER RECOMMENDED SHEATH SIZE - PREDICTING WHEN TO UPSIZE FROM THE START	73
PERICARDIAL EFFUSION REQUIRING CATHETER OR SURGICAL BASED INTERVENTION IN PATIENTS IMPLANTED WITH WATCHMAN PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION IN THE UNITED STATES	73
EMBOLIZATION AND ACUTE RIGHT VENTRICULAR SHOCK DUE TO CARDIAC CALCIFIED AMORPHOUS TUMOR IN A PATIENT WITH ANTI-PHOSPHOLIPID ANTIBODIES	73
LARGE VENTRICULAR SEPTAL DEFECT AS COMPLICATION OF MYOCARDIAL INFARCTION: A TALE OF LIMITED TRANSITIONS	73
TAKOTSUBO CARDIOMYOPATHY (TCM) AND REFRACTORY SHOCK EXACERBATED BY LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION (LVOTO)	72
EFFECT OF ECMO INITIATION TIMING ON TRICUSPID VALVE SURGERY OUTCOMES	72
RACIAL DISPARITIES IN PATIENTS IMPLANTED WITH A WATCHMAN DEVICE: A NATIONAL PERSPECTIVE	71

FORGOTTEN BUT NEVER GONE, CARDIAC BERIBERI	71
SHORT-TERM PROGNOSTIC IMPLICATIONS OF B-TYPE NATRIURETIC PEPTIDE IN TRANSCATHETER MITRAL VALVE REPAIR	71
PREVALENCE OF LEFT ATRIAL SCAR IN PATIENTS WITH COEXISTENT ATRIAL FIBRILLATION AND OBSTRUCTIVE SLEEP APNEA	70
ADVERSE PROGNOSTIC PREDICTORS AMONG PATIENTS PRESENTING WITH OUT-OF-HOSPITAL CARDIAC ARREST AND A SHOCKABLE RHYTHM	70
SHEDDING LIGHT ON THE ROLE OF ENDTHELIAL-DERIVED EXTRACELLULAR VESICLES IN CANCER THERAPY RELATED CARDIAC DYSFUNCTION PATHOGENESIS	69
TELEHEALTH CARE BEFORE AND DURING COVID-19: TRENDS AND QUALITY IN A LARGE HEALTH SYSTEM	69
SAFETY AND EFFECTIVENESS OF THERMOCOOL ST CATHETER FOR ABLATION OF PERSISTENT ATRIAL FIBRILLATION USING REAL-WORLD DATA	69
FAILURE OF THE SURGICAL ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION: THE IMPORTANCE OF PREOPERATIVE LEFT ATRIAL AND RIGHT ATRIAL FUNCTION ESTIMATED BY CONVENTIONAL AND SPECKLE-TRACKING ECHOCARDIOGRAPHY	68
CLINICAL OUTCOMES OF UNPROTECTED LEFT MAIN CORONARY ARTERY PERCUTANEOUS CORONARY INTERVENTION IN AUSTRALIAN NON-SURGICAL CENTRES	68
MULTIPLE PACING POINTS POST AV NODE ABLATION: A BETTER RESPONSE	67
INTRAVASCULAR ULTRASOUND GUIDED ZERO CONTRAST PERCUTANEOUS CORONARY INTERVENTION IN CHRONIC KIDNEY DISEASE PATIENTS: FEASIBILITY AND SHORT TERM OUTCOME	67
COVID-19 INDUCED MYOPERICARDITIS AND CARDIAC TAMPONADE: A DIAGNOSTIC DILEMMA	66
CLINICAL CHARACTERISTICS INCLUDING FAMILY HISTORY BETWEEN EARLY-ONSET AND LATE-ONSET LONE ATRIAL FLUTTER ACROSS RACE-ETHNICITY	66
SERONEGATIVE IMMUNE-MEDIATED NECROTIZING MYOPATHY COMPLICATED BY CARDIOGENIC SHOCK AND CARDIAC ARREST	66
CLINICAL CHARACTERISTICS AND OUTCOMES AMONG PATIENTS UNDERGOING HIGH-RISK PERCUTANEOUS CORONARY INTERVENTIONS WITH ONE OR TWO OPERATORS: INSIGHTS FROM THE VA CART PROGRAM	65
DETECTION OF HYPERTROPHIC CARDIOMYOPATHY BY ARTIFICIAL INTELLIGENCE-ENABLED ELECTROCARDIOGRAPHY IN CHILDREN AND ADOLESCENTS	65
ATRIAL FUNCTIONAL MITRAL REGURGITATION ADVERSE OUTCOMES WITH ASSOCIATED HEART FAILURE	65
UTILIZATION OF BIG DATA AND REAL-TIME NATURAL LANGUAGE PROCESSING FOR IDENTIFICATION OF ABDOMINAL AORTIC ANEURYSMS FROM RADIOLOGY REPORTS	64
HYPERTROPHIC CARDIOMYOPATHY WITHOUT HYPERTROPHY: MASQUERADERS OF OUTFLOW OBSTRUCTIVE PHYSIOLOGY WITH NORMAL LV MASS	64
INCREMENTAL ROLE OF LEFT ATRIAL AND RIGHT VENTRICULAR STRAINS FOR PREDICTING CARDIOVASCULAR OUTCOME IN HEART FAILURE PRESERVED EJECTION FRACTION PATIENTS: A MACHINE LEARNING APPROACH	64
GENDER DISPARITIES IN THE IN-HOSPITAL OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT ASSISTED CHRONIC CORONARY TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTIONS	64
WALKING IMPAIRMENT IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE AFTER LOWER EXTREMITY REVASCULARIZATION	64
INCREMENTAL PROGNOSTIC UTILITY OF CT-FFR IN PATIENTS WITHOUT KNOWN CORONARY ARTERY DISEASE UNDERGOING CORONARY COMPUTED TOMOGRAPHIC ANGIOGRAPHY	63
FAILURES TO ANTICOAGULATE ATRIAL FIBRILLATION DURING INDEX HOSPITALIZATION: A SINGLE ACADEMIC CENTER RETROSPECTIVE OBSERVATIONAL STUDY	63
CHARACTERISTIC FINDINGS OF MICROVASCULAR DYSFUNCTION ON CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH INTERMEDIATE CORONARY STENOSIS	63
POSITIONAL AND PAROXYSMAL HYPOXEMIA - A DIAGNOSTIC CHALLENGE	63
PSYCHOTHERAPY FOR ICD AND CRT PATIENTS: VIRTUAL VERSUS TRADITIONAL DELIVERY METHODS	62
18F-SODIUM FLUORIDE POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY IN ACUTE AORTIC SYNDROME	62
DETECTION AND DIFFERENTIATION OF CARDIAC AMYLOIDOSIS USING [124]I-P5+14 PET/CT IMAGING AND THE CORRELATION WITH CLINICAL BIOMARKERS	62
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS MANIFESTING AS ACUTE CARDIOMYOPATHY	62
EFFICACY OF CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY IN ASSESSING REGRESSION OF CORONARY ARTERY DISEASE	62
CAN ARTIFICIAL INTELLIGENCE QUANTIFY LV EJECTION FRACTION INSTANTLY AND ACCURATELY FROM POINT-OF-CARE ECHOCARDIOGRAMS PERFORMED BY MEDICAL RESIDENTS ON CRITICALLY-ILL PATIENTS?	61
BIOMECHANICAL FLOW MODELING USING PATIENT-SPECIFIC 3D PRINTED MODEDLS FOR SURGICAL DECISION-MAKING IN ANOMALOUS AORTIC ORIGIN OF CORONARY ARTERY	61
IMPACT OF HEART FAILURE ON OUTCOMES IN PATIENTS HOSPITALIZED WITH CRITICAL LIMB ISCHEMIA	61
RATE VERSUS RHYTHM CONTROL FOR ATRIAL FIBRILLATION IN THE MODERN ERA- - A SYSTEMATIC REVIEW AND META-ANALYSIS	61
CHLORHEXIDINE SCRUBBING IN PATIENTS UNDERGOING HIGH RISK CARDIAC IMPLANTABLE ELECTRONIC DEVICE PROCEDURES: A PROPENSITY SCORE MATCHED ANALYSIS	61
MOBILE CARDIAC MONITOR - EARLY HOSPITAL DISCHARGE PROGRAM (TAVR)	60
LVHNET: DETECTING CARDIAC STRUCTURAL ABNORMALITIES FROM CHEST X-RAYS USING CONVOLUTIONAL NEURAL NETWORKS	60
COLCHICINE ISN’T ALWAYS THE ANSWER!	59
CLEARED SARS-COV-2 INFECTION IS ASSOCIATED WITH LOWER RISK PULMONARY EMBOLISM	59
CHRONIC CHAGAS DISEASE PRESENTING AS FOUR-CHAMBER INTRACARDIAC THROMBI	59
EFFICACY AND SAFETY OF EDOXABAN IN FRAIL PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE ELDERCARE-AF TRIAL	59
IMPACT OF INTERHOSPITAL TRANSFER ON OUTCOMES IN ACUTE PULMONARY EMBOLISM	58
VENTRICULAR TACHYCARDIA PRIOR TO CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION WAS NOT ASSOCIATED WITH REDUCED SURVIVAL: A SINGLE CENTER EXPERIENCE	58
THE DYEVERT CONTRAST REDUCTION SYSTEM AND CONTRAST INDUCED NEPHROPATHY: IS IT ANY BETTER?	58
CARDIOVASCULAR HEALTH CHARACTERISTICS IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE	58
PREVALENCE OF ATRIAL FIBRILLATION IN PATIENTS ADMITTED WITH PULMONARY EMBOLISM AND ITS EFFECT ON IN-HOSPITAL OUTCOMES	58
JOINT PAINS AND A RACING HEART- VENTRICULAR TACHYCARDIA AS AN INITIAL PRESENTATION OF UNDERLYING SCLERODERMA RELATED AUTOIMMUNE MYOCARDITIS	58
NOVEL AUTOMATED CHA2DS2-VASC CALCULATOR HELPS DETERMINE HIGH-RISK PATIENTS FOR ANTICOAGULATION	58
MAJOR ADVERSE CARDIAC EVENTS AND VENOUS THROMBOEMBOLISM RISK WITH JAK INHIBITORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS	57
A CASE OF CONFLICTING HEMODYNAMICS: HYPERTROPHIC CARDIOMYOPATHY AND STRESS CARDIOMYOPATHY	57
ECHOCARDIOGRAPHIC MEASURES OF RIGHT VENTRICLE SIZE AND FUNCTION PREDICT ELEVATED PULMONARY VASCULAR RESISTANCE IN PEDIATRIC PATIENTS	57
DIRECT-TO-CONSUMER GENETIC TESTING AS A NOVEL METHOD OF DIAGNOSING NON-ISCHEMIC CARDIOMYOPATHY	56
THE AIR IS EVERYWHERE	56
IN-HOSPITAL CARDIAC ARREST COMPLICATING ACUTE MYOCARDIAL INFARCTION: TEMPORAL TRENDS AND OUTCOMES BASED ON MANAGEMENT STRATEGY	56
CTLA-4 AND PD-1 BLOCKING AGENTS EXERTES CARDIOTOXIC, PRO-FIBROTIC AND PRO-INFLAMMATORY EFFECTS IN CELLULAR AND PRECLINICAL MODELS	56
PULMONARY ARTERY CATHETER USE AND MORTALITY IN PATIENTS WITH CARDIOGENIC SHOCK: A META-ANALYSIS	56
PRACTICE PATTERNS AND OUTCOMES ASSOCIATED WITH ATHERECTOMY USE FOR PERIPHERAL VASCULAR INTERVENTION: INSIGHTS FROM UNITED STATES CLAIMS DATA	55
CANDIDA ENDOCARDITIS REQUIRING URGENT VALVE REPLACEMENT COMPLICATED BY STRESS CARDIOMYOPATHY AND TORSADES DE POINTES	55
CABG VERSUS PCI FOR A COMPLEX TRAUMA PATIENT WITH SEVERE TRIPLE VESSEL DISEASE	55
TIME-UPDATED ANALYSIS OF THORACIC AORTIC ANEURYSM SIZE TO ESTIMATE LONG-TERM RISKS OF AORTIC DISSECTION	55
EOSINOPHILIC CARDIOMYOPATHY IN A PATIENT WITH CHRONIC EOSINOPHILIC LEUKEMIA	55
BURNOUT SYNDROME IN THE CARDIAC CATHETERIZATION LAB	55
ESTIMATED CARDIOVASCULAR BENEFITS OF INCLISIRAN IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE	55
EARLY CARDIOVASCULAR RISK AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA	54
ONE-YEAR COST-EFFECTIVENESS OF CYP2C19- GUIDED DE-ESCALATION AND ESCALATION OF P2Y12 INHIBITORS IN VETERANS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS CORONARY INTERVENTION	54
MATERNAL AND FETAL OUTCOME OF THE FIRST PREGNANCY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY	54
THE EFFECT OF LONG-TERM USE OF ASPIRIN ON THE OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH A HISTORY OF CORONARY ARTERY DISEASE AND DIABETES	54
TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS	54
A CASE OF SEVERE LEFT MAIN ATRESIA DISCOVERED IN AN ASYMPTOMATIC 65 YEAR OLD MAN.	54
A RARE CASE OF SYNTHETIC MARIJUANA USE LEADING TO CARDIAC ARREST	53
TRANSCATHETER MITRAL VALVE INTERVENTION IN PATIENTS WITH CANCER	53
HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY	53
CONTEMPORARY TRENDS OF PERCUTANEOUS CORONARY INTERVENTION AND COMPLICATIONS IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM NATIONAL READMISSIONS DATABASE	53
CONSTRICTIVE PERICARDITIS: DON'T DRESS IT, STRIP IT	53
MYOCARDIAL BRIDGE IN HEART TRANSPLANT PATIENTS: A RETROSPECTIVE ANALYSIS OF POST-TRANSPLANT INVASIVE CORONARY ARTERY ASSESSMENTS USING CORONARY ANGIOGRAPHY AND INTRAVASCULAR ULTRASOUND	52
FROM COLD AND UNKNOWN TO HOME FOR THE HOLIDAYS, THE USE OF VA-ECMO IN HYPOTHERMIC CARDIAC ARREST	52
ANGIOVAC EXTRACTION OF A FREE-FLOATING RIGHT HEART THROMBUS-IN-TRANSIT	52
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER	52
ISCHEMIA INDUCED BY A GIANT RIGHT CORONARY ARTERY ANEURYSM	52
ILIAC STENT MIGRATING INTO THE RIGHT VENTRICLE : AN UNUSUAL CAUSE OF HEART FAILURE	51
OUTCOMES OF ACUTE CORONARY SYNDROME IN PATIENTS WITH INTELLECTUAL DISABILITY: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE	51
MATERNAL CARDIAC EVENTS AMONG PREGNANT WOMEN WITH M-WHO CLASS III AND IV AT THE FIRST CARDIO-OBSTETRIC CLINIC IN IRAQ	51
SEX DIFFERENCES IN EVALUATION AND MANAGEMENT OF YOUNG ADULTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH CHEST PAIN	51
COMPARATIVE CARDIOVASCULAR EFFECTIVENESS AND SAFETY OF INDIVIDUAL ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: A MULTINATIONAL PARTICIPANT-LEVEL ASSESSMENT FROM LEGEND-H	51
UNEXPECTED FINDING OF SINGLE BIFID PAPILLARY MUSCLE ANOMALY IN A PATIENT PRESENTING WITH ANGINA PECTORIS	51
EARLY POST-TRANSPLANT OUTCOMES IN LVAD PATIENTS UNDERGOING HEART TRANSPLANT VIA USE OF THE SHERPAPAK CARDIAC TRANSPORT SYSTEM AS COMPARED WITH TRADITIONAL COLD STORAGE: INSIGHTS FROM THE GUARDIAN REGI	51
IMPROVING HYPERTENSION CONTROL IN THE UNITED STATES: UNDERSTANDING RACIAL/ETHNIC DIFFERENCES IN THE BLOOD PRESSURE CASCADE	51
MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES (MINOCA) MIMICKERS IN ST-ELEVATION MYOCARDIAL INFARCTION	51
INCIDENTAL AORTO-LEFT ATRIAL APPENDAGE FISTULA COMPLICATING A WATCHMAN PROCEDURE	51
ASSOCIATION OF CHOLESTEROL EFFLUX CAPACITY WITH ADVERSE CARDIOVASCULAR OUTCOMES - A META-ANALYSIS	50
THE VA-BEACH DIET STUDY: A COMPARISON OF PLANT-BASED, MEDITERRANEAN, PALEOLITHIC AND DASH DIETS ON LIPID AND BIOMETRIC PARAMETERS	50
A UNIQUE CASE OF AXILLARY AND BRACHIAL ARTERY THROMBOSIS AFTER LEFT RADIAL ACCESS FOR CORONARY ANGIOGRAPHY	50
DAYS ALIVE OUT OF HOSPITAL FOR PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AND CORONARY ARTERY DISEASE TREATED WITH CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: FINDINGS FROM THE STICH TRIAL	50
TCT-78 miRNA-200b—A Potential Biomarker Identified in a Porcine Model of Cardiogenic Shock and Mechanical Unloading	50